JPMorgan Upgrades Teva Pharma (TEVA) to Neutral, 'we remain cautious'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. INSP
8. HNGE
9. MRVL
10. MTCH

Go back to JPMorgan Upgrades Teva Pharma (TEVA) to Neutral, 'we remain cautious'

Teva Pharma (TEVA) PT Raised to $17 at Jefferies, 'Innovation Strategy Resonating'

March 11, 2024 12:31 PM EDT

Jefferies analyst Glen Santangelo raised the price target on Teva Pharma (NYSE: TEVA) to $17.00 (from $16.00) while maintaining a Buy rating.

The analyst comments "We hosted TEVA CEO, CFO, CMO and IR for mtgs and think that while the co is clearly... More